Veeda Lifesciences Partners with Mango Sciences to Innovate AI in Clinical Trials Services

Veeda Lifesciences Partners with Mango Sciences for AI Innovation in Clinical Trials



Ahmedabad, India — July 8, 2025
In a significant move to revolutionize the clinical trial landscape, Veeda Lifesciences, a global contract research organization (CRO), has announced an investment partnership with Mango Sciences, a Boston-based data and AI company focused on healthcare. This collaboration is poised to harness the power of artificial intelligence (AI) to enhance the speed, efficiency, and quality of clinical trial services across Veeda's expanding global network.

This strategic alliance will enable Veeda to utilize Mango Sciences' AI-driven Querent™ platform, significantly improving patient recruitment diversity and representation in clinical trials worldwide. Mahesh Bhalgat, Executive Director and CEO of Veeda Clinical Research Limited, emphasized, “Our partnership will position Veeda as an AI-driven oncology drug development organization capable of meeting the increasing demand for diversity in clinical trials, aligning with the expectations of both regulators and pharmaceutical companies.” He further remarked on the rarity of CROs specialized in oncology that will have access to such cutting-edge technology.

The investment in Mango Sciences aims to advance Veeda’s mission of modernizing technology and undergoing digital transformation to enhance operational efficiency and quality assurance throughout its clinical research operations. With the Querent™ platform, Veeda will automate the precise identification of patients and expand its reach across Europe. This technological upgrade is expected to streamline processes, improve data management capabilities, and set higher quality standards through broader representation of non-Caucasian populations in trials, ultimately resulting in better clinical outcomes.

Dr. Mohit Misra, founder and CEO of Mango Sciences, shared his insights about the collaboration: “We are integrating large language models and generative AI into Querent™ to enhance operational effectiveness and improve real-world evidence, ultimately identifying the right drug for the right patient.” This visionary statement epitomizes the future of personalized medicine, where patient-centric approaches are paramount.

Moreover, Veeda has fortified its status as a technology-oriented CRO through strategic investments and the recent acquisition of Health Data Specialists. This strengthens its capability to tap into oncology patient cohorts both in India and Europe, while gaining exclusive access to eligible patient groups. The partnership not only seeks to maintain a competitive edge in the CRO sector but also to provide invaluable services to pharmaceutical and biopharmaceutical clients on a global scale.

About Veeda Lifesciences


Veeda Lifesciences (Veeda Clinical Research Limited) offers a comprehensive range of services across different stages of the drug development value chain, supporting small to medium-sized biotechnology and pharmaceutical companies. Their expertise spans from non-clinical and preclinical development to clinical pharmacology and various clinical trials modalities. For more information, visit Veeda Lifesciences.

About Mango Sciences


Mango Sciences is a healthcare data and AI technology firm dedicated to transforming patient care through advanced data solutions and analytics. Founded by industry veterans with extensive experience in healthcare, life sciences, and data analytics, Mango Sciences is driven by a passion for improving patient representation and access to comprehensive healthcare solutions. For more information, visit Mango Sciences.

This strategic partnership lays the groundwork for enhanced clinical studies and innovative patient treatments, a true testament to the potential of AI in revolutionizing healthcare practices. As Veeda Lifesciences and Mango Sciences embark on this journey together, the implications for the future of clinical trials and patient care are vast, promising a new era of efficiency and diversity in medical research.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.